THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION
Cardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time, arterial hypertension (AH) is one of the most common CV pathologies, which, according to foreign researchers, affects about 30–45% of the general population [2] and about 40–47% of the population acc...
Main Authors: | S. A. Berns, R. I. Stryuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1764 |
Similar Items
-
ACE inhibitor fosinopril in the treatment of hypertension: potential benefits
by: AO Konradi
Published: (2014-12-01) -
ANTIHYPERTENSIVE AND VASOPROTECTIVE EFFECTS OF FOSINOPRILE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: N. Yu. Grigorieva, et al.
Published: (2018-01-01) -
Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2006-10-01) -
The role of fosinopril in the treatment and prevention of cardiovascular diseases
by: G. A. Baryshnikova
Published: (2015-12-01) -
Efficacy of fosinopril and amlodipine in pediatric primary hypertension: a single-center observational study
by: Hui Wang, et al.
Published: (2023-10-01)